Forigerimod

N/A

Report date: 2024/02/05 20:04:22
NME

Base Information

Drug NameForigerimod
Drug Alias NameRigerimodLupuzorIPP-201101CEP-33457SyB-1001 +[6
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsLupus Erythematosus, Systemic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumUnited States +[13
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesImmupharma Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCephalon IncImmupharma Plc
Active IndicationsN/A
Inactive IndicationsLupus Erythematosus, Systemic

Other Information

ATC CodeN/A
Related LinksN/A